UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038312
Receipt number R000043355
Scientific Title Stereotactic body radiotherapy and radiofrequency ablation for early hepatocellular carcinoma-A prospective observational study
Date of disclosure of the study information 2019/10/16
Last modified on 2019/12/20 09:18:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Potential abscopal effect of stereotactic body radiotherapy on the recurrence of hepatocellular carcinoma: An exploratory observation study

Acronym

Effect of stereotactic body radiotherapy on the recurrence
of hepatocellular carcinoma: An exploratory observation study

Scientific Title

Stereotactic body radiotherapy and radiofrequency ablation for early hepatocellular carcinoma-A prospective observational study

Scientific Title:Acronym

Stereotactic body radiotherapy and radiofrequency ablation for early hepatocellular carcinoma-A prospective observational study

Region

Japan


Condition

Condition

Hepatocellular carcinoma

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

By comparing the local and nonlocal recurrence rate after stereotactic body radiotherapy (SBRT) and radiofrequency abration to early hepatocellular carcionoma (HCC), and by analyzing the association between the post-treatment changes in immunostimulatory serum factors and HCC recurrence, the inhibitory effect of SBRT on HCC recurrence through potential abscopal effect is exploratory evaluated.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Local and nonlocal Recurrence

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Solitary hepatocellular carcinoma (HCC) no larger than 30 mm in diameter without portal invasion or extrahepatic metastasis
(2)HCC diagnosed with early enhancement and late washout by contrast-enhanced computed tomography or by EOB-magnetic resonance imaging
(3) Primary, or recurred HCC being detected after longer than 6 months from initial treatament

Key exclusion criteria

(1) Child-Pugh Score C
(2) Performance Status 3-4
(3) Pregnant or potentially pregnant female

Target sample size

280


Research contact person

Name of lead principal investigator

1st name Atsumasa
Middle name
Last name Komori

Organization

National Hospital Organization Nagasaki Medical Center

Division name

Clinical Research Center

Zip code

856-8562

Address

Kubara 2-1001-1, Omura city, Japan

TEL

0957-52-3121

Email

komori.atsumasa.qr@mail.hosp.go.jp


Public contact

Name of contact person

1st name Atsumasa
Middle name
Last name Komori

Organization

National Hospital Organization Nagasaki Medical Center

Division name

Clinical Research Center

Zip code

856-8562

Address

Kubara 2-1001-1, Omura city, Japan

TEL

0957-52-3121

Homepage URL


Email

komori.atsumasa.qr@mail.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Nagasaki Medical Center

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization funding for operating expenses

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization central institutional review board

Address

Higashigaoka-2-5-21, Meguro ku, Tokyo

Tel

03-5712-5075

Email

700-kenkyu@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

独立行政法人国立病院機構長崎医療センター(長崎県) 
独立行政法人国立病院機構仙台医療センター(宮城県) 
独立行政法人国立病院機構横浜医療センター(神奈川県)
独立行政法人国立病院機構まつもと医療センター(長野県) 
独立行政法人国立病院機構大阪医療センター(大阪府) 
独立行政法人国立病院機構呉医療センター(広島県) 
独立行政法人国立病院機構岡山医療センター(岡山県) 
独立行政法人国立病院機構小倉医療センター(福岡県)
独立行政法人国立病院機構名古屋医療センター(愛知県)
独立行政法人国立病院機構京都医療センター(京都府) 
独立行政法人国立病院機構大阪南医療センター(大阪府) 
独立行政法人国立病院機構嬉野医療センター(佐賀県) 
独立行政法人国立病院機構東京医療センター(東京県) 
独立行政法人国立病院機構熊本医療センター(熊本県) 
独立行政法人国立病院機構別府医療センター(大分県)
独立行政法人国立病院機構渋川医療センター(群馬県) 
独立行政法人国立病院機構旭川医療センター(北海道) 
独立行政法人国立病院機構高崎総合医療センター(群馬県) 
独立行政法人国立病院機構九州がんセンター(福岡県)
独立行政法人国立病院機構愛媛医療センター(愛媛県)
独立行政法人国立病院機構福山医療センター(広島県)


Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 09 Month 13 Day

Date of IRB

2019 Year 09 Month 13 Day

Anticipated trial start date

2019 Year 10 Month 16 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observational study


Management information

Registered date

2019 Year 10 Month 16 Day

Last modified on

2019 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043355


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name